For 10 million worldwide patients with Parkinson’s disease, news out of Japan that a large pharmaceutical corporation is seeking approval for a new stem cell-based treatment should be hugely encouraging. Following a successful clinical trial in which seniors between 50 and 59 years of age received injections of induced pluripotent stem cells (iPS) and saw […]
The post Company Seeks Sale and Manufacturing Approval for Successful Stem Cell Parkinson’s Treatment appeared first on Good News Network.